LaFleur & Godfrey’s Pfizer PFE Stock Holding History

LaFleur & Godfrey’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,925	Closed	-$263K	–	140
2023 Q3	$263K	Sell	7,925 -697	-8%	-$24.6K	0.04%	106
2023 Q2	$316K	Sell	8,622 -1,241	-13%	-$48.3K	0.05%	105
2023 Q1	$402K	Buy	9,863 +125	+1%	+$5.4K	0.07%	96
2022 Q4	$499K	Buy	9,738 +11	+0.1%	+$527	0.08%	90
2022 Q3	$426K	Sell	9,727 -4,221	-30%	-$205K	0.08%	92
2022 Q2	$731K	Sell	13,948 -64	-0.5%	-$3.26K	0.12%	84
2022 Q1	$725K	Sell	14,012 -14,740	-51%	-$765K	0.1%	91
2021 Q4	$1.7M	Sell	28,752 -113	-0.4%	-$5.6K	0.22%	75
2021 Q3	$1.24M	Buy	28,865 +6,729	+30%	+$298K	0.17%	86
2021 Q2	$867K	Buy	22,136 +1,053	+5%	+$40.9K	0.12%	93
2021 Q1	$764K	Sell	21,083 -1,551	-7%	-$55.1K	0.15%	70
2020 Q4	$833K	Sell	22,634 -2,029	-8%	-$74.4K	0.17%	72
2020 Q3	$859K	Buy	+24,663	New	+$865K	0.19%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LaFleur & Godfrey's PFE Position: Q4 2023 in Review

LaFleur & Godfrey sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,925 shares — an estimated $263K sold.

LaFleur & Godfrey first reported a position in PFE in Q3 2020 and held it in 13 quarters. The position peaked at $1.7M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

LaFleur & Godfrey reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
LaFleur & Godfrey sold 7,925 Pfizer shares in Q4 2023, an estimated $263K.
LaFleur & Godfrey first reported a position in Pfizer in Q3 2020 and held it in 13 quarters.
LaFleur & Godfrey's Pfizer position peaked at $1.7M in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on LaFleur & Godfrey's 13F filing for Q4 2023, filed 18 Jan 2024.